The recently concluded Healthy China - 2023 Life and Health Industry Cross-border Cooperation "Changping-Fortune 500 Dialogue" (hereinafter referred to as the "Event") focused on hot topics such as innovative development of biomedicine and cross-border cooperation in the life and health industry. The Event welcomed more than 10 Fortune Global 500 companies, including Danaher, BD (Becton, Dickinson and Company), Takeda, and Sanofi, and more than 30 foreign-funded enterprises from countries such as France and Germany, as well as over 200 participants including the key figures of governmental authorities, China's top enterprises, foreign chambers of commerce in China and financial institutions, and experts and scholars.

During the Event, the Implementation Plan for Opening up the Full Industry Chain of the Biomedicine Industry in Beijing and the latest policies of Changping District in key areas such as the pharmaceutical and health industry, beauty economy, and sci-tech innovation finance were interpreted. The current development status and future plans for the pharmaceutical and health industry were also presented to the audience. Representatives of foreign chambers of commerce in China and leading biomedical enterprises were invited to deliver thematic speeches on topics such as intellectual property protection, medical technology innovation, and international cooperation, based on the current situation. During the section "High-level Dialogue", officials from the relevant municipal departments of Beijing, and representatives from international organizations and Chinese and foreign enterprises, engaged in in-depth discussions and exchanged views on the policy trends of the development of innovative medical devices in Beijing, new opportunities for cross-border cooperation in the life and health industry, and Changping's business environment, among others.

The Event enhanced the government and industrial parks' communication with the foreign-funded enterprises among the Fortune Global 500 ones, foreign chambers of commerce in China, industrial organizations, financial institutions, experts, and scholars, laying a solid foundation for further in-depth cooperation and project implementation. Moving forward, Changping District will continue to optimize service for enterprises, build a world-class investment environment, maintain close ties with the Fortune Global 500 enterprises to jointly build a cross-border cooperation platform for the life and health industry, and fully leverage the innovative advantages of the "Champion Bio", an industrial base for the biomedical industry in Changping District to greatly accelerate the development of the local pharmaceutical and health industry.

(Source: Changping District People's Government of Beijing Municipality)